SCHEMBL13708826

SCHEMBL13708826

COCCN(C)C(=O)c1sc2c(c1OC)c(=O)n(C)c1ccccc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 5/20 0.45
HTR2C P28335 1/20 0.43
HSD17B10 Q99714 4/20 0.40
KMT2A Q03164 1/20 0.40
TSHR P16473 1/20 0.40
KDM4E B2RXH2 6/20 0.39
POLB P06746 4/20 0.39
CACNA1B Q00975 1/20 0.39
APBA1 Q02410 1/20 0.39
ALDH1A1 P00352 4/20 0.39
HPGD P15428 3/20 0.39
MAPT P10636 6/20 0.39
GAA P10253 1/20 0.39
ACKR3 P25106 1/20 0.39
MAPK1 P28482 1/20 0.38
RXFP1 Q9HBX9 2/20 0.38
ABL1 P00519 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1057428 0.92 TP53 (0.41) TP53HTR2CHSD17B10KMT2ATSHR
SCHEMBL1057287 0.91 KDM4E (0.43) TP53HSD17B10KMT2ATSHRKDM4E
SCHEMBL1060920 0.89 TP53 (0.47) TP53HTR2CHSD17B10KMT2ATSHR
SCHEMBL10314290 0.88 KMT2A (0.47) TP53HSD17B10KMT2ATSHRKDM4E
SCHEMBL1060561 0.88 TP53 (0.40) TP53HTR2CHSD17B10KMT2ATSHR
SCHEMBL10314377 0.86 TP53 (0.41) TP53HTR2CHSD17B10KMT2ATSHR
SCHEMBL10314401 0.84 KDM4E (0.41) TP53HTR2CHSD17B10KMT2AKDM4E
SCHEMBL1057527 0.84 MAPT (0.53) TP53TSHRKDM4EPOLBCACNA1B
SCHEMBL1056680 0.83 KDM4E (0.44) TP53HTR2CHSD17B10KMT2ATSHR
Trifluoroacetic Acid SCHEMBL1063966 0.83 KMT2A (0.43) TP53HSD17B10KMT2ATSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009107850-A2 FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-09-03 WO disclosed